======= SIN3B =======
== Gene Information ==
* **Official Symbol**: SIN3B
* **Official Name**: SIN3 transcription regulator family member B
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23309|23309]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O75182|O75182]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SIN3B&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SIN3B|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/607777|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Acts as a transcriptional repressor. Interacts with MXI1 to repress MYC responsive genes and antagonize MYC oncogenic activities. Interacts with MAD-MAX heterodimers by binding to MAD. The heterodimer then represses transcription by tethering SIN3B to DNA. Also forms a complex with FOXK1 which represses transcription. With FOXK1, regulates cell cycle progression probably by repressing cell cycle inhibitor genes expression. {ECO:0000250|UniProtKB:Q62141}.
|HDAC interact|
|PAH|
|autosome|
|Y chromosome|
|X chromosome|
|XY body|
|Sin3 complex|
|histone deacetylase activity|
|histone deacetylation|
|protein deacetylation|
|protein deacylation|
|macromolecule deacylation|
|chromatin|
|transcription corepressor activity|
|histone modification|
|covalent chromatin modification|
|chromatin binding|
|regulation of lipid metabolic process|
|chromatin organization|
|negative regulation of transcription by RNA polymerase II|
|chromosome organization|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|negative regulation of gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp125|GSK461364A 0.005μM R03 exp125]]|-2.65|
|[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|-2.28|
|[[:results:exp391|Pomalidomide 20μM R07 exp391]]|-2.18|
|[[:results:exp463|Caffeine 2600μM R08 exp463]]|-2.06|
|[[:results:exp272|CHIR-124 0.04μM R06 exp272]]|-2.05|
|[[:results:exp513|ONC212 0.15μM R08 exp513]]|1.72|
|[[:results:exp448|Ammonium tetrathiomolybdate 10μM R08 exp448]]|1.77|
|[[:results:exp515|PU-H71 1μM R08 exp515]]|1.81|
|[[:results:exp532|TIC10 10μM R08 exp532]]|1.81|
|[[:results:exp435|JQ1 0.8μM R08 exp435]]|1.85|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 7812
* **Expression level (log2 read counts)**: 6.55
{{:chemogenomics:nalm6 dist.png?nolink |}}